MEDICINES CO /DE Deferred Tax Assets, Net of Valuation Allowance
MEDICINES CO /DE had Deferred Tax Assets, Net of Valuation Allowance of $120.29 million as of 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2019-02-27
- 2018-12-31: Deferred Tax Assets, Net of Valuation Allowance $120.29M.
- 2017-12-31: Deferred Tax Assets, Net of Valuation Allowance $62.14M.
- 2016-12-31: Deferred Tax Assets, Net of Valuation Allowance $144.01M.
- 2015-12-31: Deferred Tax Assets, Net of Valuation Allowance $120.33M; Deferred Tax Assets, Net of Valuation Allowance as first filed $93.82M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2018-12-31 | $120.29M 10-K · filed 2019-02-27 | |
| 2017-12-31 | $62.14M 10-K · filed 2019-02-27 | |
| 2016-12-31 | $144.01M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $120.33M 10-K · filed 2017-03-01 | $93.82M 10-K · filed 2016-02-29 |
| 2014-12-31 | $120.86M 10-K · filed 2016-02-29 | $105.54M 10-K · filed 2015-03-02 |
| 2013-12-31 | $120.46M 10-K · filed 2015-03-02 | |
| 2012-12-31 | $79.80M 10-K · filed 2014-03-03 | |
| 2011-12-31 | $106.20M 10-K · filed 2013-03-01 | |
| 2010-12-31 | $45.73M 10-K · filed 2012-02-29 |